unfavourable Doctors Foster and Smith Chlorhexidine Salve Generic Name: chlorhexidine salve Dosage Form: FOR ANIMAL USE ONLY Print this page Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here. For Dogs, cats, and small pets DIRECTIONS Clean area thoroughly. Apply 1 to 3 times daily, to minor cuts, burns, and scrapes. ACTIVE INGREDIENT 1.0% Chlorhexidine Diacetate OTHER INGREDIENTS Petrolatum, Boric Acid, Propylene CGlycol, Sucrose Octa Acetate, Fragrance, Vitamin A Palmtate, dl-Alpha Tocopheryl Acetate (source of Vitamin E), Cholecalciferol (source of Vitamin D3). CAUTION For external use only. Avoid contact with eyes. Consult your veterinarian in cases of deep or puncture wounds, animal bites, serious burns or if redness and irritation persists or increases. STORAGE Keep tightly closed at room temperature. Protect from freezing. For animal use only Keep out of reach of children and pets to avoid accidental ingestion For Questions Or To Re-Order: 1-800-562-7169 Doctors Foster and Smith Septi-Soothe Salve Veterinarian Formulated Advanced Salve Gentle, Antiseptic Formula NET WT 0.85 OZ (24 g) DOCTORS FOSTER AND SMITH chlorhexidine salve Product Information Product Type OTC ANIMAL DRUG Item Code (Source) NDC:65713-909 Route of Administration TOPICAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CHLORHEXIDINE (CHLORHEXIDINE) CHLORHEXIDINE 0.24 g in 24 g Inactive Ingredients Ingredient Name Strength PETROLATUM BORIC ACID PROPYLENE GLYCOL SUCROSE VITAMIN A PALMITATE ALPHA-TOCOPHEROL, DL- Packaging # Item Code Package Description 1 NDC:65713-909-08 1 TUBE (BOX) in 1 BOX 1 NDC:65713-909-09 24 g in 1 TUBE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/01/2001 Labeler - Doctors Foster and Smith (122135148) Registrant - United Pet Group (931135730) Establishment Name Address ID/FEI Operations JUNGLE LABORATORIES CORPORATION 032615270 manufacture Revised: 03/2010 Doctors Foster and Smith FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Recently Approved Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... Ogivri Ogivri (trastuzumab-dkst) is a HER2 / neu receptor antagonist biosimilar to Herceptin indicated for... Sublocade Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the... More predict
a devoted Doctors Foster and Smith Chlorhexidine Salve getting old
EmoticonEmoticon